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CT angiography in the detection of carotid body 
enlargement 
in patients with hypertension and heart failure 
Sreejit Nair, Ajay Gupta, Marat Fudim, Christopher Robinson, Vinay Ravi, Sandra Hurtado-Rua, Zoar 
Engelman, Kyungmouk S. Lee, C. Douglas Phillips, Akhilesh K. Sista 
Introduction 
The carotid bodies are the primary sensors of hypoxemia 
and the main sensors of carbon dioxide and pH outside 
of the brain. They have been found to be hyperactive in 
various disease states. Historical literature from the 1970s 
provided evidence that the carotid bodies are enlarged in 
respiratory disease states (asthma, chronic obstructive 
pulmonary disease (COPD), and emphysema) [1, 2]. 
Several human cadaver studies indicated a significant 
correlation between the com-bined weights of the carotid 
bodies and the weight of both the right and left ventricles [1, 
2]. This finding suggests that the carotid bodies could play 
a role in the development or pro-gression of 
cardiovascular diseases like heart failure (HF). Subsequent 
studies have found carotid body (CB) enlargement in animals 
with genetic hypertension (HTN; spontaneous hy-pertensive 
rats) [3- 5]. Modern literature provides increasing 
evidence that the carotid bodies play a major role in modulat-
ing sympathetic activation in disease states like HF and HTN 
[6-10]. 
A recent study investigating the role of neck computed 
tomography angiography (CTA) in detecting the CB found 
that the CB can be reliably detected on CTA [11]. To our 
knowledge, there has not been any prior imaging study cor-
relating CB size to specific disease states. The purpose of this 
case-control study was to compare CB sizes in patients with 
both HF and HTN with those of controls without HF, HTN, or 
any other potentially confounding conditions (cirrhosis, respi-
ratory disease, lactic acidosis, or hemoglobinopathy) using 
CTA. 
Methods 
The study was approved by the institutional review board. 
Retrospective review was performed on 323 consecutive pa-
tients who had neck CTA exams in 2011. Patients with HF and 
HTN were identified based on a diagnosis in the medical 
record within 6 months of the CTA exam. Confounding 
exclusionary conditions were placed in three main categories: 
(1) hepatic disorders, such as cirrhosis, (2) pulmonary disor-
ders, such as COPD or chronic interstitial lung disease, and (3) 
hematologic or metabolic abnormalities, such as lactic acido-
sis or hemoglobinopathy. Patients with insufficient chart in-
formation to confirm the presence or absence of these condi-
tions were excluded from the study. From the 323 neck CTAs 
screened, 17 adult patients with HF and HTN were identified. 
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Fig. 1 Patient flow diagram describing the selection of cases and controls 
Table 1 Demographics for HF vs. control groups 
Median age (years) 
Gender (male, %) 
Population size 
HFandHTN 
57.1 
76 
17 
Controls 
44.0 
64 
14 
Fourteen patients had conclusive information excluding the 
presence of the above confounding conditions and were iden-
tified as controls (Fig. 1). 
Two board-certified radiologists blinded to the patients' 
case or control status made consensus bilateral CB measure-
ments on the CTA exams. Our departmental CTA protocol 
uses bolus tracking via premonitoring scans at the level of the 
aortic arch, with an ROI placed within the ascending aorta. 
Helical 0.625-mm collimated images were acquired from the 
inferior aspect of the aortic arch to the superior aspect of the 
frontal sinus, with a pitch of 1.0 at 120 kV. One hundred 
milliliters of contrast was injected through an 18-gauge 
antecubital fossa intravenous line at a rate of 4 mVs. The 
matrix size of the scanner was 512 x512. Measurement tools 
allowed measurement of differences of 0.1 mm. Measure-
ments were made using a standardized protocol with PACS 
(picture archiving and communication system) measurement 
tools at 200 % magnification to determine longitudinal and 
transverse axial dimensions [11 ]. The CB was identified on 
each side by searching for an avidly enhancing structure in the 
characteristic location of the CB at the inferomedial aspect of 
the carotid bifurcation. Given the consistent oval or elliptical 
configuration of the CB on axial images, the difficulties in 
obtaining an accurate craniocaudal measurement, and the 
spatial limitations of multiplanar coronal reformatted images, 
Fig. 2 CTA axial image at the level of the carotid body in a 56 year old 
male control patient demonstrates normal right carotid body (arrowhead) 
at the bifurcation of the right internal (black arrow) and external (white 
arrow) carotid arteries 
the axial cross-sectional area of each CB was computed as the
area of an ellipse. A value of 0 was recorded for any CB not
visualized. CB areas were compared in the case and control
groups using a paired t test. The right case CBs were com-
pared with the right control CBs, and the left case CBs were
compared with the left control CBs.
Results
The patient demographic breakdown for HF and HTN pa-
tients vs. control groups is given in Table 1. Representative
control and case images are shown in Figs. 2 and 3, respec-
tively. The right CB was identified in 65 % of HF and HTN
patients (11/17) and in 57 % of controls (8/14). The left CB
was identified in 83 % of HF and HTN patients (15/18) and
in 36 % of controls (5/14). The smallest detected carotid
body measured 1 mm×1 mm in longitudinal and transverse
dimensions in a control patient. The right CB demonstrated
a mean cross-sectional area of 2.79 mm2 in HF vs.
1.40 mm2 in controls (p =0.02). The left CB demonstrated
a mean cross-sectional area of 3.13 mm2 in HF and HTN
patients vs. 1.53 mm2 in controls (p =0.03) (Tables 2 and 3).
No difference between the right and left CBs was detected in
either group. While the right- and left-sided CBs in the HF
and HTN groups showed a strong positive correlation, the
CBs in the control group showed no or only negligible
positive correlation (Tables 4 and 5).
Discussion
The CB may contribute to increased sympathetic activation in
cardiovascular diseases like HF and HTN [10]. Prior pathologic
studies have uncovered a positive correlation between the in-
creased size of the CB and the presence of these disease states
[1, 12]. Proposed mechanisms for hyperactivity and enlarge-
ment of these chemoreceptors include decreased perfusion,
changes in acid-sensing ion channels, and shifts in the relative
activities of hypoxia-inducible factors (HIF1 and HIF2)
[12–15]. Analysis of the CB in an animal model of genetic
HTN showed the glomus cells to be hypertrophied, suggesting
an increase in protein synthesis and angiogenesis [16].
The CB is a highly perfused organ [17], making it visible on
CTA. In 2011, Nguyen et al. confirmed the ability to consistently
detect the carotid body in a series of patients who underwent
CTA for various indications [11]. In our retrospective blinded
case–control study of 17 patients with HF and HTN and 14
controls, we tested the hypothesis that CTA can be used to show
enlargement of the CB in HF and HTN. We found that the CB
cross-sectional areas measured on CTA are significantly in-
creased inHF andHTNcompared to controls. Similar toNguyen
et al., we have shown a positive correlation between the size of
the right and left CBs. However, we show this correlation only
with HF and HTN patients and not with the control population,
possibly due to our relatively smaller sample size.
The pathophysiologic significance of the CB in HF and
HTN has been recognized in both historical and more recent
literature [10, 18]. Interestingly, overactivity of the CB has
been linked to a higher mortality rate in patients with HF [10,
19]. Importantly, it is still unclear whether this overactivity is a
cause or effect of its anatomical size. The temporal relation-
ship between CB size changes and the onset of HTN and CHF
is also unclear. However, as seen in this study, CTA may be a
non-invasive tool to visualize the CB. With further validation
and confirmation, the ability to reliably detect “pathological”
Fig. 3 CTA axial image in a 51 year old male with heart failure and
hypertension demonstrates enlarged right carotid body (arrowhead) at
the bifurcation of the right internal (black arrow) and external (white
arrow) carotid arteries
Table 2 Comparison of cross sectional areas of the right CB in HF and
HTN groups versus control
HF and HTN Control p value
Mean size (mm2) 2.51 1.06 0.04
Variance (mm2) 5.35 1.31
Table 3 Comparison of cross sectional areas of the left CB in HF and
HTN groups versus control
HF and HTN Control p value
Mean size (mm2) 2.99 1.03 0.02
Variance (mm2) 6.49 2.87
Table 4 Comparison of cross sectional areas of the right and left CBs in
HF and HTN groups
Right Left Pearson coefficient Student's t test
Mean size (mm2) 2.51 2.99 0.41 0.57
CB enlargement with CTA may make it the imaging modality
of choice for monitoring treatments aimed at modulating CB
activity. Since radiation exposure is a potential hazard of CTA,
the utility of MRI/MRA in this setting should also be
investigated.
Given the retrospective nature of this study and the limita-
tions of chart review, there may have been some degree of
inaccuracy selecting cases and controls. However, to limit this
potential bias, we were strict in including only cases and
controls with adequate chart documentation of inclusion and
exclusion criteria. Altitude also may affect CB size and func-
tion, but the retrospective nature of the study did not allow us
to collect this specific information. Most patients, however,
were drawn from the New York City metropolitan area and
were therefore near sea level. A second limitation was our
relatively low N. The small sample size limited our ability to
perform additional and potentially informative analyses such
as correlating ejection fraction/blood pressure with CB size
and distinguishing between the effects of HF and HTN on CB
size. This small sample size may also account for the greater
variation in CB size compared with that of Nguyen et al.
However, the significant difference between the CB cross-
sectional areas of HF and HTN cases and controls demon-
strates that our study was sufficiently powered to provide
meaningful preliminary data regarding our primary outcome
measure. A high percentage of the left CBs were not visual-
ized in our analysis; it is possible that such an observation may
be due to suppression by the contralateral hypertrophied CB.
Further studies will hopefully clarify the influence of one
carotid body on the other. Validation of these results will
require additional prospective studies with larger patient
populations.
Conclusion
Our case–control series provides CTA evidence that the ca-
rotid bodies are enlarged in HF and HTN. CTA could poten-
tially guide and monitor future therapies directed at carotid
body overactivity. Further validation of these results with a
larger prospective study is required.
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